SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Amgen Inc. (AMGN)
An SI Board Since December 1996
Posts SubjectMarks Bans Symbol
1906 112 0 AMGN
Emcee:  trevor john wilkinson Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1481Anemia-Drug Limits to Hurt Amgen By PETER LOFTUS May 11, 2007 4:49 p.m. [WSJ] Doc Bones-5/14/2007
1480mstar: Analyst Note 05-11-2007 At a full-day meeting Thursday to discuss the mopgcw-5/13/2007
1479Amgen downgraded in wake of FDA panel meeting By Carolyn Pritchard, MarketWatchJGoren-5/12/2007
1478Amgen stock is broken and will be under pressure for some time. The advertising-JGoren-5/11/2007
1477The ESA landscape seems to change by the day. You saw the stumble for Fibrogen?tuck-5/11/2007
1476Can't say AMGN has been "strong" today, but it's made a steadytom pope-5/11/2007
1475Hi Tuck, Affymax is getting whacked today coz of the concerns with Amgen. I am dr.praveen-5/11/2007
1474Merrill: Proposed Label Changes Leave Room for Interpretation At a cancer paneltom pope-5/11/2007
1473great callmopgcw-5/11/2007
1472<i>the drugs will be contraindicated in cancers for which adverse signals tom pope-5/10/2007
1471IHub's palindromy summarizes the vote: investorshub.com ESA companies losttuck-5/10/2007
1470>>FDA Panel OKs New Limits on Anemia Drugs Thursday May 10, 3:24 pm ET FDAtuck-5/10/2007
1469Seems as though the ODAC panel isn't going too well. The 145 study that juituck-5/10/2007
1468Doctors Reap Millions for Anemia Drugs [NYT] By ALEX BERENSON and ANDREW POLLACDoc Bones-5/9/2007
1467Here's ML's take Tuck: FDA Briefing Document Suggests need for further tom pope-5/8/2007
1466Briefing documents are out today ahead of the panel meeting. I haven't looktuck-5/8/2007
1465Good luck. I just continue to hold for the long haul, if she dips below $55 (domopgcw-5/3/2007
1464Medarex to Get Amgen Milestone Payment Thursday May 3, 7:54 am ET Medarex to Rmopgcw-5/3/2007
1463Barrons online out with positive fund manager comments re AMGN's prospects. tuck-5/3/2007
1462Confusion Reigns Over Proper Use Of Anemia Drug By MARILYN CHASE May 3, 2007; Pamopgcw-5/3/2007
1461The bill that could rock biotech Measure to create generic biotech drugs could hJGoren-4/30/2007
1460forbes: Amgen Says Aranesp Not Deadly Evelyn M. Rusli, 04.19.07, 7:04 PM ET Amopgcw-4/28/2007
1459EGFR Market in Colorectal Cancer: investorshub.comDewDiligence_on_SI-4/23/2007
1458>>Amgen's First Quarter 2007 Revenue Increased 15 Percent to $3.7 Billtuck-4/23/2007
1457Affymax(R) Announces Phase 2 Clinical Trial Results of Once-Per-Month Hematide(Tnigel bates-4/23/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News